Abstract:New findings: What is the central question of this study? What is the protective benefit of n-3 polyunsaturated fatty acids (PUFAs) on liver fibrosis and what are the relevant signalling pathways in a transgenic mouse model overexpressing the mfat-1 enzyme? What is the main finding and its importance? n-3 PUFA elevation strongly prevented carbon tetrachloride (CCl4 )-induced hepatic damage and inhibited the activation of hepatic stellate cells. n-3 PUFAs suppressed CCl4 -induced activation of mTOR, elevated Bcl-2 expression, and reduced Bax level, suggesting that n-3 PUFAs can render strong protective effects against liver fibrosis and point to the potential of mfat-1 gene therapy as a treatment modality. Abstract: Liver fibrosis is a reversible wound healing response with excessive accumulation of extracellular matrix proteins. It is a globally prevalent disease with ultimately severe pathological consequences. However, very few current clinical therapeutic options are available. Nutritional addition of n-3 polyunsaturated fatty acids (PUFAs) can delay and lessen the development of liver fibrosis. Herein, this study examined the protective benefit of n-3 PUFAs on liver fibrosis and the relevant signalling pathways using a transgenic mouse model overexpressing the mfat-1 enzyme that converts n-6 to n-3 PUFAs. Male C57BL/6 wild-type and mfat-1 transgenic mice were administered carbon tetrachloride (CCl4 ) or control corn oil by intraperitoneal injection. Blood alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were subsequently measured. CCl4 -induced hepatic damage and fibrosis were assessed using haematoxylin-eosin and Masson's trichrome staining. Western blot assays were used to detect and quantify fibrosis-related proteins and mechanistic target of rapamycin (mTOR) and B-cell lymphoma 2 (Bcl-2)/Bcl-2-associated X protein (Bax) signalling components. The direct effect of docosahexaenoic acid (DHA) on primary hepatic stellate cells (HSCs) was also investigated in a co-culture experiment. n-3 PUFAs, as a result of mfat-1 activity, had a strong protective effect on liver fibrosis. The elevation of ALT and AST induced by CCl4 was significantly lessened in the mfat-1 mice. Histological determination revealed the protective effects of n-3 PUFAs on liver inflammation and collagen deposition. Co-incubation with DHA reduced the expression of profibrogenic factors in the primary HSCs. Moreover, mfat-1 transgenic mice showed significant reduction of proteins that are involved in mTOR and Bcl-2/Bax signalling pathways. Collectively, these results suggest that n-3 PUFA elevation strongly prevents CCl4 -induced hepatic damage by directly inhibiting the activation of HSCs and regulating the basal activity of the mTOR and Bcl-2/Bax signalling pathways. Gene therapy applying mfat-1 and elevating n-3 PUFAs represents a promising treatment strategy to prevent liver fibrosis.

Effect of n-3 polyunsaturated fatty acids on induction of hypoxia inducible factor-2 alpha in C 2C 12 myotubes

Effect of N-3 Polyunsaturated Fatty Acids on Induction of Hypoxia Inducible Factor-2 Alpha in C2C12 Myotubes

EFFECTS OF N-3/N-6 POLYUNSATURATED FATTY ACIDS ON RETINAL PIGMENT EPITHELIAL CELLS INJURED BY HIGH-GLUCOSE AND THEIR MECHANISMS

Effect of Essential Fatty Acids on Glucose-Induced Cytotoxicity to Retinal Vascular Endothelial Cells

Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism

Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and n-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure

Different effects of omega-3 fatty acids on the cell cycle in C2C12 myoblast proliferation

DHA/EPA Improves GLUT4 Translocation, Glycogen Synthesis and Aerobic Glycolysis in Skeletal Muscle of Db/db Mice

PUFA Treatment Affects C2C12 Myocyte Differentiation, Myogenesis Related Genes and Energy Metabolism

EPA Inhibits the Inhibitor of Κbα (Iκbα)/nf-Κb/muscle RING Finger 1 Pathway in C2C12 Myotubes in a PPARγ-dependent Manner

Concurrent EPA and DHA Supplementation Impairs Brown Adipogenesis of C2C12 Cells

Investigating the Role of EPA and DHA on Cellular Oxidative Stress; Profiling Antidiabetic and Antihypertensive Potential

Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice.

Effects of n-3 polyunsaturated fatty acids high fat diet intervention on the synthesis of hepatic high-density lipoprotein cholesterol in obesity-insulin resistance rats

Epa Inhibits The Inhibitor Of Kappa B Alpha (I Kappa B Alpha)/Nf-Kappa B/Muscle Ring Finger 1 Pathway In C2c12 Myotubes In A Ppar Gamma-Dependent Manner

Effect of Conjugated Linoleic Acid on Inhibition of Prolyl Hydroxylase 1 in Hearts of Mice

Effects of n-3 polyunsaturated free fatty acids on liver and muscle insulin receptor and GluT-4 in the insulin resistance rats induced by high fat-feeding

Synergistic effects of punicic acid and alpha lipoic acid ameliorate inflammatory and metabolic genes expression in C2C12 myoblast cells under oxidative stress condition

Endogenous production of <i>n</i>-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways

Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways

Protective Role of N6/n3 PUFA Supplementation with Varying DHA/EPA Ratios Against Atherosclerosis in Mice